Sun Pharma to Cease Manufacturing Generic Alzheimer's Drug

Following its legal defeat in the patent infringement lawsuit against the US drug maker Forest Laboratories, Sun Pharmaceuticals plans to stop manufacturing or marketing the generic version of Alzheimer's drug, reported The Economic Times.

According to the news source, the Indian pharmaceutical company will not manufacture the drug during the life of the patent, unless all asserted claims of Forest Laboratories's patent for Namenda have been invalidated.

Forest's patent for Namenda expires in 2010. However, Forest Laboratories has filed an application to extend its Alzheimer's drug patents until 2013, the news source said.

Forest Laboratories is also reportedly waging patent battles against Lupin, Orchid Chemicals & Pharmaceuticals, Wockhardt, and Ranbaxy in the US district court for patent violation of Namenda.

 

Comments

Post a Comment

Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Image
GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut    Vox Author of GOP Tax Plan Says Children's Health Insurance Program Is Held Up “Because We Don't Have Money ...    The Intercept Nevada wins short reprieve in child health care funds fight    Sacramento Bee Ben McAdams: Congress to Tiny Tim: 'No health insurance for you.'    Salt Lake Tribune Full coverage
Read more

Trump wants more mental health care; Alabama says it's trying

Image
Trump wants more mental health care; Alabama says it's trying    AL.com Budget undercuts Trump focus on mental health, school safety    Yahoo News Mental health awareness license plates offered by New York State DMV    Buffalo News Trump wants to 'tackle the difficult issue of mental health?' He should put his money where his mouth is.    Washington Post Full coverage
Read more